Tags
Language
Tags
September 2025
Su Mo Tu We Th Fr Sa
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4
    Attention❗ To save your time, in order to download anything on this site, you must be registered 👉 HERE. If you do not have a registration yet, it is better to do it right away. ✌

    ( • )( • ) ( ͡⚆ ͜ʖ ͡⚆ ) (‿ˠ‿)
    SpicyMags.xyz

    Pediatric Psychopharmacology For Primary Care (repost)

    Posted By: interes
    Pediatric Psychopharmacology For Primary Care (repost)

    Pediatric Psychopharmacology For Primary Care by Dr. Mark A Riddle M.D.
    English | 2015 | ISBN: 1581102755 | 225 pages | PDF | 5 MB

    Confidently prescribe, monitor, and manage medications for childhood mental health disorders.
    This game-changing resource from the American Academy of Pediatrics (AAP) arms you with a unique strategic approach - plus practice-tested, condition-specific treatment recommendations.

    Free bonus digital tool! Get instant answers on specific conditions and medications from your desktop or mobile device!

    Evidence-based conceptual framework
    A clear, straightforward methodology - based on current research and clinical experience - defines discrete levels of psychotropic agents and spells out level-specific roles and responsibilities.

    Group 1:Medications FDA-approved for youth for ADHD, anxiety, and depression - disorders for which pediatric primary care providers commonly initiate treatment and assume prescribing and monitoring responsibilities.
    Administration and management information for each drug agent includes:
    Rationale for use
    Evidence supporting efficacy and safety
    Initial dosing and subsequent adjustments
    Measuring therapeutic success
    When to consult or refer
    Group 2: Medications FDA-approved for youth, typically prescribed by specialists but often monitored in the primary care setting: antipsychotics, mood stabilizers, antidepressants, anxiolytics, and sleep aids. To support primary care clinician's collaborative role, usage rationales, efficacy data, and adverse effect profiles are specified for all of these agents.

    Group 3: Medications not FDA-approved for youth that primary care clinicians will likely encounter. To support primary care clinician's collaborative role, efficacy data and adverse effect profiles are specified for these agents.

    Proven, practice-focused guidance
    Hands-on help spanning the therapeutic process:
    Assessing for common disorders
    Assessing for psychiatric comorbidities
    Identifying medication needs
    Informed consent
    Monitoring patient progress
    Managing side effects
    Managing multiple medications
    Stopping or changing medications

    My nickname - interes